Rifampicin and isoniazid resistance not promote fluoroquinolone resistance in Mycobacterium smegmatis.
<h4>Background</h4>The emergence of drug-resistant Tuberculosis (TB) has made treatment challenging. Although fluoroquinolones (FQs) are used as key drugs in the treatment of multidrug-resistant tuberculosis (MDR-TB), the problem of FQs resistance is becoming increasingly serious. Rifampicin (RIF) r...
Shranjeno v:
| Principais autores: | , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Public Library of Science (PLoS)
2025-01-01
|
| Serija: | PLoS ONE |
| Online dostop: | https://doi.org/10.1371/journal.pone.0315512 |
| Oznake: |
Brez oznak, prvi označite!
|